Michael Leek
Amministratore Delegato presso TCB Newco Ltd.
Posizioni attive di Michael Leek
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Amministratore Delegato | - | - |
| Presidente | - | - | |
| Fondatore | - | - |
Storia della carriera di Michael Leek
Precedenti posizioni note di Michael Leek
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Amministratore Delegato | 01/01/2013 | 01/06/2021 |
| Presidente | 01/01/2013 | 14/02/2023 | |
| Direttore Tecnico/Scientifico/R&S | 14/02/2023 | 01/06/2023 | |
| Fondatore | 01/01/2013 | 01/06/2023 | |
Intercytex Ltd.
 Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Direttore operativo | 01/01/2000 | 03/02/2006 |
TC Biopharm Ltd.
 TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Amministratore Delegato | 01/01/2014 | - |
| Fondatore | 01/01/2014 | - |
Formazione di Michael Leek
| University of Leeds | Doctorate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 6 |
Posizioni
| Chief Executive Officer | 3 |
| Founder | 3 |
| Chairman | 2 |
Settori
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Aziende private | 3 |
|---|---|
Intercytex Ltd.
Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Health Technology |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
- Borsa valori
- Insiders
- Michael Leek
- Esperienza
